Quick Take
Shockwave Medical (SWAV) intends to raise $75 million from the sale of its common stock, per an amended registration statement.
The company sells medical instruments to assist in removing calcified plaque in arteries and peripheral blood vessels.
SWAV is growing quickly from a low base but I have concerns about the high valuation management is asking investors to pay. I'll look for a lower entry point post-IPO.
Company & Technology
Santa Clara, California-based Shockwave Medical was founded in 2009 to improve patient outcomes via their intravascular lithotripsy [IVL] system that